Solid tumors account for more than 60%of all the pediatric malignancies and contribute substantially to the disease burden in China[1].Currently,there are five primary treatment strategies:surgery,radiation therapy,co...Solid tumors account for more than 60%of all the pediatric malignancies and contribute substantially to the disease burden in China[1].Currently,there are five primary treatment strategies:surgery,radiation therapy,conventional chemotherapy,molecular targeted agents and immunotherapy.While the first three methods are nearing their potential limits,the latter two are advancing rapidly,with new approaches continually emerging and resulting in positive clinical outcomes.展开更多
基金support from the Natural Science Foundation of China(No.81470304)the Key Project of Zhejiang Provincial Science and Technology Department(No.2019C03032).
文摘Solid tumors account for more than 60%of all the pediatric malignancies and contribute substantially to the disease burden in China[1].Currently,there are five primary treatment strategies:surgery,radiation therapy,conventional chemotherapy,molecular targeted agents and immunotherapy.While the first three methods are nearing their potential limits,the latter two are advancing rapidly,with new approaches continually emerging and resulting in positive clinical outcomes.
